Somatic mutations identified by targeted sequencing in whole AITL and PTCL-NOS tissues were separately analyzed in a CD19+ cell fraction enriched for B cells and a PD1+ cell fraction enriched for tumor cells, both isolated by microdissection of individual samples [67]. The gene discussed is PDCD1; the disease is angioimmunoblastic T-cell lymphoma.